Nalaganje...
Use of the Trypanosoma cruzi Recombinant Complement Regulatory Protein To Evaluate Therapeutic Efficacy following Treatment of Chronic Chagasic Patients
One of the greatest concerns in Chagas' disease is the absence of reliable methods for the evaluation of chemotherapy efficacy in treated patients. The tests available to evaluate cure after the specific treatment are the complement-mediated lysis (CoML) and flow cytometry tests, but they are n...
Shranjeno v:
| izdano v: | J Clin Microbiol |
|---|---|
| Main Authors: | , , , , , |
| Format: | Artigo |
| Jezik: | Inglês |
| Izdano: |
American Society for Microbiology (ASM)
2004
|
| Teme: | |
| Online dostop: | https://ncbi.nlm.nih.govhttps://pmc.ncbi.nlm.nih.gov/articles/PMC344465/ https://ncbi.nlm.nih.govhttps://pubmed.ncbi.nlm.nih.gov/14766840/ https://ncbi.nlm.nih.govhttps://doi.org/10.1128/JCM.42.2.707-712.2004 |
| Oznake: |
Označite
Brez oznak, prvi označite!
|